Blockage of JNK pathway enhances arsenic trioxide-induced apoptosis in human keratinocytes

Huei-Sheng Huang1, Zi-Miao Liu, Duang-Yang Hong

  • 1Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. huanghs@mail.ncku.edu.tw

Insights

Arsenic trioxide (ATO) impacts cell death pathways. JNK1 inhibits ATO-induced p21 expression, a mechanism involving TGIF domains, and JNK inhibition enhances ATO-induced apoptosis in keratinocytes.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Toxicology

Background:

  • Arsenic compounds exhibit dual roles as carcinogens and therapeutic agents.
  • Arsenic trioxide (ATO) induces cell death via mechanisms like apoptosis and cell cycle arrest.
  • Previous research linked ATO-induced p21 activation to A431 cell death, involving ERK1/2 and JNK1 signaling.

Purpose of the Study:

  • To investigate the inhibitory role of JNK1 in ATO-induced p21 expression.
  • To identify the specific domains of TGIF responsible for its interaction with JNK1 and its effect on p21 expression.
  • To evaluate the impact of JNK inhibition on ATO-induced apoptosis in keratinocytes.

Main Methods:

  • Over-expression of JNK1 in A431 cells.
  • GST pull-down assay and fluorescence resonance energy transfer (FRET) analysis.
  • Reporter assays to determine TGIF domain function.
  • Flow cytometry to assess apoptosis in HaCaT cells after treatment with JNK inhibitor SP600125 and ATO.

Main Results:

  • JNK1 overexpression inhibited p21 expression in A431 cells, associated with HDAC1 and TGIF.
  • The N-terminal domain (1-108) of TGIF was critical for binding with c-Jun.
  • The C-terminal domain (138-272) of TGIF was required to suppress ATO-induced p21 expression.
  • JNK inhibitor SP600125 enhanced ATO-induced apoptosis in HaCaT keratinocytes.

Conclusions:

  • JNK1 plays an inhibitory role in ATO-induced p21 expression through interactions involving TGIF and HDAC1.
  • Specific domains of TGIF mediate its inhibitory effects on p21 expression.
  • Inhibiting JNK1 potentiates ATO-induced apoptosis in keratinocytes, suggesting a therapeutic avenue.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...